Regeneron logo

PharmD Program Associate - Clinical Operations & Program Management

Regeneron
August 24, 2026
On-site
Tarrytown, NY
Operations
Program Track: 24-month rotational experience within one of the following tracks: Clinical Operations & Program Management; Clinical Sciences; Regulatory Strategy; Regulatory Labeling & Advertising/Promotion; Safety Sciences. Optional elective rotation to gain exposure to a different functional area.

Clinical Operations & Program Management: Support management of clinical trials by contributing to trial set-up, execution, conduct and close out. Participate in strategic decision making, governance interactions, and integrated drug development planning.

Discover Your Role:
- Draft documents integral to clinical sites and regulatory submissions
- Analyze data from clinical studies for interactions with ethics committees, senior management, regulatory authorities, and others
- Manage third-party vendors and maintain timelines of key results
- Develop regulatory strategies for clinical development programs
- Analyze safety data to characterize product safety profile across the development lifecycle
- Work with program mentors to improve skills toward professional goals
- Opportunity to travel to clinical sites and/or meetings with health authorities

This Role Requires:
- PharmD from an ACPE-accredited College of Pharmacy (post-doctoral graduates); PhD in a life science area may also be considered
- Complete PharmD and/or PhD by Summer 2027
- Prior internship or rotational experience in Pharmaceutical/Biotech (preferred)
- Exposure/familiarity evaluating clinical trials, scientific literature, and data
- Highly motivated; career foundation in Clinical Sciences, Global Clinical Operations, Regulatory Affairs, and/or Safety Sciences
- Eligible to work in the U.S. on a permanent basis

Application Details:
- Submit a resume and cover letter specifying the track of interest; if applying to multiple tracks, rank in order of preference
- Applications accepted: August 24th, 2026 – September 11th, 2026